Male breast cancer (MBC) is a relatively rare disease accounting for only about 1% of all breast cancers diagnosed in the United States, with approximate lifetime risk of  1:1000 for developing breast cancer compared to 1:8 for females. Identified risk factors for the development of MBC were advanced age, increased estrogen exposure such as obesity, cirrhosis, Klinefelter syndrome, and history of irradiation. This paper describes a 67-year-old male patient who was pre-operatively diagnosed with Adenocarcinoma Stage IIA of the right breast associated with Gynecomastia Grade IIA on the left. Patient underwent Modified Radical Mastectomy and was given chemotherapeutic regimen post-operatively.  The treatment algorithm for MBC still follows the pathway for female breast cancers with Modified Radical Mastectomy as the preferred surgical approach and an adjuvant chemotherapy with hormonal therapy since majority of MBC are Luminal A. Since breast screening is not routinely done for the male population, few studies also exists hence early detection imposes a great challenge for managing male breast carcinomas.

To Be Updated